Is your goal to effectively introduce your product to the market?  Do you need a single partner to support development, clinical trial services, commercialization, and more?

CMIC Group can be your reliable partner. As the largest CRO in Japan, we take pride in supporting clinical trials across more than 13 countries in the Asia South Pacific region. Over the past 5 years, we have supported clinical trials over a range of therapeutic areas, with specialization in oncology, infectious disease including vaccines, metabolic disease, and neurology fields.

Areas We Support:

While these are just some of the areas we support, we are not limited, as we are a full-service clinical research organization with a dynamic range of expertise and resources at your disposal.

• Registry Study
• Observational Study
• Phases II/III Clinical Trials
• Phase IV Clinical Trials
• Post-marketing Surveillance

See why 97% of our clients would choose CMIC again and recommend our services. Contact our experts today.

Our Edge in Asia Pacific Clinical Trials

Supporting Your Asia Pacific Clinical Trial Success

CMIC will help you navigate the regulatory landscape, identify clinical trial sites, and recruit patients. We also offer a variety of cost-saving solutions to help you get your product to market faster, as the APAC market offers numerous benefits, including faster approvals.

• Reduce the time and cost of clinical trials
• Gain access to a large and diverse patient population
• Maximize your chances of regulatory approval quickly and efficiently

Why consider the Asia Pacific Region for Clinical Trials?

The Asia-Pacific region offers several advantages that make it an attractive destination for clinical trials. With its vast population, diverse demographics, and cutting-edge research institutions, an increasing number of pharmaceutical and biotech companies are seeking to conduct clinical trials in Asia.